paroxetine has been researched along with Bipolar Disorder in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.52) | 18.7374 |
1990's | 19 (28.79) | 18.2507 |
2000's | 35 (53.03) | 29.6817 |
2010's | 9 (13.64) | 24.3611 |
2020's | 2 (3.03) | 2.80 |
Authors | Studies |
---|---|
Condiotte, A; Govada, V | 1 |
Bianchi, L; Del Duca, E; Esposito, M; Fargnoli, MC; Giunta, A; Manfreda, V; Troisi, A | 1 |
Mimura, M; Mizushima, J; Nio, S; Suzuki, T; Tada, M; Uchida, H | 1 |
Calabrese, JR; Findling, RL; Lingler, J; McNamara, NK; Rowles, BM | 1 |
Barwell, MM; Diazgranados, N; Frank, E; Kupfer, DJ; Luckenbaugh, DA; Mallinger, AG; Thase, ME | 1 |
Goldstein, I; Kellner, CH; Korda, JB; Pfaus, JG | 1 |
Agambaram, V; Brecher, M; Chang, W; McElroy, SL; Merideth, C; Nordenhem, A; Olausson, B; Paulsson, B; Weisler, RH; Young, AH | 1 |
Jung, YK; Park, YM | 1 |
LeBlanc, SR; Ovanessian, MM; Parikh, SV | 1 |
Chen, PY; Chou, KJ; Huang, MC | 1 |
Bauer, M; Lewitzka, U; Pilhatsch, M; Winter, C; Wolf, R | 1 |
Blom, MB; Hartong, EG; Mulder, P; Nolen, WA; Timmermans, MA; van der Loos, ML; van Noorden, MS; Vergouwen, AC; Vieta, E | 1 |
Cruz, N; Vieta, E | 1 |
Amsterdam, JD; McHenry, LB | 1 |
Hsiao, MC; Liu, CY | 1 |
Arnone, D; Hansen, L; Kerr, JS | 1 |
Arita, S; Morishita, S | 4 |
Salerian, AJ | 1 |
Ramasubbu, R | 2 |
Shelton, RC; Stahl, SM | 1 |
Goldstein, D; Green, S; Santangelo, CG | 1 |
Baroni, S; Betti, L; Cassano, GB; Catena, M; Dell'Osso, B; Giannaccini, G; Lucacchini, A; Marazziti, D | 1 |
Krol, DG; Nolen, WA | 1 |
Bauer, MS; Kogan, JN; Marangell, LB; Sachs, G; Thase, ME; Wisniewski, SR | 1 |
Grochowik, AM | 1 |
Rybakowski, JK; Łojko, D | 1 |
Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R | 1 |
Allen, MH; Bowden, CL; Calabrese, JR; Dennehy, EB; Fossey, MD; Friedman, ES; Gyulai, L; Hauser, P; Ketter, TA; Marangell, LB; Martinez, JM; Miklowitz, DJ; Nierenberg, AA; Ostacher, MJ; Otto, MW; Patel, J; Rapport, D; Sachs, GS; Thase, ME; Wisniewski, SR | 1 |
John, AP; Koloth, R | 1 |
Preskorn, SH | 2 |
Jakovljevic, M; Kramaric, M; Muck-Seler, D; Mustapic, M; Nedic, G; Peles, AM; Pivac, N; Sagud, M | 1 |
Christensen, RC | 1 |
Zelwer, A | 1 |
Stokes, PE | 1 |
Ambrosio, LA; Barrese, E; Buccomino, D; Filippo, A; Marchese, G; Morelli, A; Musacchio, R; Pupo, F; Romano, FE | 1 |
Landry, P; Roy, L | 1 |
Young, C | 1 |
Fischer, P; Goessler, R; Kasper, S; Vesely, C | 1 |
Grubbs, JH | 1 |
Kraus, RP | 1 |
Oldroyd, J | 1 |
Abraham, JT; Brown, R; Meltzer, HY | 1 |
Bagli, M; Laux, G; Rao, ML; Sobanski, T | 1 |
Labbate, LA; Rubey, RN | 1 |
Folkerts, HW; Michael, N; Mücke, S; Schonauer, K; Schulze-Mönking, H; Tölle, R | 1 |
György, S; Kecskés, I; Kiss, GH; Pestality, P; Rihmer, Z | 1 |
Avci, A; Diler, RS | 1 |
Calabrese, JR; Kimmel, SE; Rapport, DJ; Shelton, MD | 1 |
Joffe, RT; MacQueen, GM; Marriott, M; Patelis-Siotis, I; Robb, JC; Young, LT | 1 |
Caputo, RM; Stern, S; Votolato, NA | 1 |
Bowden, CL; Evans, DL; Gergel, IP; Gyulai, L; Nemeroff, CB; Oakes, R; Pitts, CD; Sachs, GS | 1 |
Armani, A; Baroni, S; Cassano, GB; Dell'Osso, L; Di Nasso, E; Giannaccini, G; Lucacchini, A; Marazziti, D; Masala, I; Rossi, A | 1 |
Baldwin, DS; Hawley, CJ; Mellors, K | 1 |
Buysse, DJ; Fagiolini, A; Frank, E; Houck, PR; Kupfer, DJ; Luther, JF | 1 |
Kharaian, LV; Kolesnikov, DB; Kurikov, AV; Rapoport, SI | 1 |
Aberg-Wistedt, A; El Khoury, A; Johnson, L; Stain-Malmgren, R | 1 |
Asnis, GM; Gabbay, V; O'Dowd, MA | 1 |
Benabarre, A; Colom, F; Goikolea, JM; Martinez-Arán, A; Reinares, M; Torrent, C; Vieta, E | 1 |
Blumhardt, CL; Boyer, WF | 1 |
Larsen, T; Manniche, PM; Morsing, I; Møller, SE; Nielsen, OA; Petersen, JS; Skausig, OB | 1 |
Mertens, C; Pintens, H | 1 |
3 review(s) available for paroxetine and Bipolar Disorder
Article | Year |
---|---|
Current issues in the treatment of major depression.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Bipolar Disorder; Chronic Disease; Clinical Trials as Topic; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Incidence; Male; Middle Aged; Paroxetine; United States | 1993 |
Controlled trials in bipolar I depression: focus on switch rates and efficacy.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Controlled Clinical Trials as Topic; Double-Blind Method; Humans; Lamotrigine; Moclobemide; Paroxetine; Triazines | 1999 |
The safety profile of paroxetine.
Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Cardiovascular System; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Electrocardiography; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Placebos; Psychomotor Performance; Sleep | 1992 |
16 trial(s) available for paroxetine and Bipolar Disorder
Article | Year |
---|---|
Antidepressant dose and treatment response in bipolar depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome | 2015 |
A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Child; Child of Impaired Parents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Paroxetine; Pilot Projects; Risk Factors; Valproic Acid | 2008 |
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Quetiapine Fumarate; Severity of Illness Index; Treatment Outcome | 2010 |
Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Paroxetine; Secondary Prevention | 2010 |
Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Compounds; Male; Middle Aged; Paroxetine; Treatment Outcome; Triazines; Young Adult | 2011 |
The paroxetine 352 bipolar trial: A study in medical ghostwriting.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bipolar Disorder; Conflict of Interest; Double-Blind Method; Humans; Imipramine; Paroxetine; Scientific Misconduct; Treatment Outcome | 2012 |
Risperidone and paroxetine given singly and in combination for bipolar depression.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2004 |
Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients.
Topics: Adult; Binding Sites; Bipolar Disorder; Blood Platelets; Cell Membrane; Female; Humans; Kinetics; Lymphocytes; Male; Paroxetine; Psychotic Disorders; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2006 |
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Paroxetine; Treatment Outcome | 2007 |
Electroconvulsive therapy vs. paroxetine in treatment-resistant depression -- a randomized study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Retreatment; Treatment Failure; Treatment Outcome | 1997 |
Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Lithium Chloride; Male; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid | 2000 |
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.
Topics: Adult; Aged; Ambulatory Care; Anticonvulsants; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipramine; Lithium; Male; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Valproic Acid | 2001 |
A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.
Topics: Adult; Aged; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome; Triazoles | 2001 |
A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
Topics: Amino Acids; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists | 1991 |
A double-blind, multicentre study of paroxetine and mianserin in depression.
Topics: Antidepressive Agents; Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Mianserin; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists | 1989 |
47 other study(ies) available for paroxetine and Bipolar Disorder
Article | Year |
---|---|
Attempted "Suicide by Police" by a Patient With Bipolar I Disorder and PTSD on Paroxetine Monotherapy.
Topics: Bipolar Disorder; Humans; Paroxetine; Police; Stress Disorders, Post-Traumatic; Suicide, Attempted | 2022 |
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series.
Topics: Adult; Agoraphobia; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Lithium Carbonate; Male; Mental Disorders; Middle Aged; Nordazepam; Panic Disorder; Paroxetine; Psoriasis; Quetiapine Fumarate; Severity of Illness Index; Treatment Outcome; Valproic Acid | 2020 |
Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Female; Humans; Male; Monoamine Oxidase Inhibitors; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Time Factors; Treatment Outcome; Young Adult | 2009 |
Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy.
Topics: Bipolar Disorder; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Orgasm; Paroxetine; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Substance Withdrawal Syndrome; Time Factors | 2009 |
Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression.
Topics: Adolescent; Bipolar Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Methylphenidate; Paroxetine; Serotonin Syndrome; Treatment Outcome | 2010 |
Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Combined Modality Therapy; Comorbidity; Database Management Systems; Humans; Inositol; Lamotrigine; Multicenter Studies as Topic; Paroxetine; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Recurrence; Research Design; Risperidone; Smoking; Substance-Related Disorders; Suicide; Treatment Outcome; Triazines; United States; Vitamin B Complex | 2010 |
Restless legs syndrome following the combined use of quetiapine and paroxetine.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Middle Aged; Paroxetine; Quetiapine Fumarate; Restless Legs Syndrome | 2010 |
Antidepressants in acute bipolar depression: an inconclusive meta-analysis.
Topics: Antidepressive Agents; Bipolar Disorder; Data Interpretation, Statistical; Humans; Meta-Analysis as Topic; Paroxetine | 2011 |
Antidepressant-related hypomania in a patient with premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Female; Humans; Paroxetine; Premenstrual Syndrome | 2002 |
Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dystonic Disorders; Electroconvulsive Therapy; Humans; Male; Morpholines; Olanzapine; Paroxetine; Pirenzepine; Reboxetine | 2002 |
Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression.
Topics: Antidepressive Agents; Bipolar Disorder; Cyclopropanes; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Milnacipran; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
Induction of mania in depression by paroxetine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cohort Studies; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies | 2003 |
Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cohort Studies; Cyclopropanes; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Personality Inventory; Psychometrics; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome | 2003 |
Prevalence of induced mania in patients treated with milnacipran: a comparison with paroxetine.
Topics: Adult; Aged; Bipolar Disorder; Cohort Studies; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Prevalence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires | 2004 |
Successful treatment of sexual dysfunction with dronabinol: a case report.
Topics: Adult; Benzodiazepines; Bipolar Disorder; Dronabinol; Female; Humans; Libido; Olanzapine; Paroxetine; Psychotropic Drugs; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome; Valproic Acid | 2004 |
Antidepressant treatment-associated behavioural expression of hypomania: a case series.
Topics: Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Irritable Mood; Ischemic Attack, Transient; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Stroke | 2004 |
A case of bipolar disorder and typhoid fever.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Neuropsychological Tests; Olanzapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Typhoid Fever | 2004 |
[Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Brief report: paroxetine in younger and adult individuals at high risk for suicide.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cohort Studies; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Male; Paroxetine; Pilot Projects; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Suicide, Attempted; United States | 2006 |
Hold on tight.
Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Paroxetine; Smoking | 2006 |
L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.
Topics: Adult; Bipolar Disorder; Clomipramine; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Treatment Outcome | 2007 |
Antidepressant response in the elderly.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine.
Topics: Analgesics, Opioid; Bipolar Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Pain; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tramadol | 2007 |
Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic?
Topics: Adjustment Disorders; Adolescent; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Buspirone; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Suicide, Attempted | 2007 |
Neuroleptic malignant syndrome resulting from a complex drug-drug interaction: "I don't see 'em!".
Topics: Benztropine; Bipolar Disorder; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Middle Aged; Neuroleptic Malignant Syndrome; Paroxetine; Perphenazine; Psychotropic Drugs; Trazodone | 2007 |
The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Blood Platelets; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium Compounds; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Serotonin; Triazines | 2008 |
Paroxetine-induced psychotic mania.
Topics: Adult; Bipolar Disorder; Dose-Response Relationship, Drug; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine | 1995 |
Depression and marijuana.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Humans; Male; Marijuana Smoking; Paroxetine | 1994 |
[Efficacy and tolerability of paroxetine in the treatment of the depressive phase of bipolar disorders].
Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales | 1996 |
Withdrawal hypomania associated with paroxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Panic Disorder; Paroxetine; Substance Withdrawal Syndrome | 1997 |
A case of neuroleptic malignant syndrome and serotonin disturbance.
Topics: Akathisia, Drug-Induced; Benztropine; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Middle Aged; Neuroleptic Malignant Syndrome; Neurologic Examination; Paroxetine; Perphenazine; Receptors, Serotonin; Trazodone | 1997 |
Mania associated with serotonin selective reuptake inhibitors.
Topics: Bipolar Disorder; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1997 |
SSRI-induced mania.
Topics: Adolescent; Bipolar Disorder; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1997 |
Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine.
Topics: Adult; Antidepressive Agents, Second-Generation; Arousal; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Paroxetine; Pindolol; Recurrence; Sympatholytics | 1996 |
Paroxetine-induced mania.
Topics: Adolescent; Antidepressive Agents; Bipolar Disorder; Depression; Humans; Lithium Carbonate; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1997 |
Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Neurologic Examination; Paroxetine; Serotonin Receptor Agonists; Sumatriptan | 1997 |
Serotonin syndrome after lithium add-on medication to paroxetine.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Drug Interactions; Female; Humans; Lithium; Middle Aged; Paroxetine; Serotonin | 1997 |
Lamotrigine for treatment-refractory bipolar disorder.
Topics: Anticonvulsants; Bipolar Disorder; Drug Therapy, Combination; Humans; Lamotrigine; Male; Middle Aged; Paroxetine; Thyroxine; Triazines | 1997 |
SSRI supplementation of antimanic medication in dysphoric mania.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Depression; Drug Therapy, Combination; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1998 |
SSRI-induced mania in obsessive-compulsive disorder.
Topics: Bipolar Disorder; Child; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1999 |
Serotonergic antidepressants and urinary incontinence.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride | 2000 |
Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Sertraline | 2001 |
Decreased platelet [3H]paroxetine binding sites in suicide attempters.
Topics: Adolescent; Adult; Bipolar Disorder; Carrier Proteins; Comorbidity; Depressive Disorder; Female; Humans; Male; Mental Disorders; Middle Aged; Paroxetine; Radioligand Assay; Receptors, Drug; Risk Factors; Serotonin Plasma Membrane Transport Proteins; Suicide, Attempted | 2001 |
Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2001 |
[A case of a rare side effects of paxil therapy in a male patient with irritable colon syndrome].
Topics: Adult; Bipolar Disorder; Colonic Diseases, Functional; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2001 |
Effects of long-term lithium treatment on monoaminergic functions in major depression.
Topics: Adult; Aged; Bipolar Disorder; Blood Platelets; Carrier Proteins; Depressive Disorder, Major; Female; Humans; Lithium Carbonate; Lysergic Acid Diethylamide; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Radioligand Assay; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2001 |
Combined antidepressant treatment: a risk factor for switching in bipolar patients.
Topics: Anticonvulsants; Antidepressive Agents; Bipolar Disorder; Bupropion; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Paroxetine; Risk Factors; Treatment Outcome | 2002 |